multiple sclerosis Clinical Trials and Research
Also known as: ms, demyelinating disease, sclerosis multiplex, disseminated sclerosis · ICD-10: G35
Multiple sclerosis (MS) is a chronic disease where the immune system attacks the protective covering of nerves in the brain and spinal cord, disrupting communication. Clinical trial research focuses on new therapies to slow disease progression, manage symptoms, and repair nerve damage. Find a Trial helps patients search for active studies.
Search multiple sclerosis trials →
Common questions about multiple sclerosis clinical trials
Who can participate in multiple sclerosis clinical trials?
Eligibility criteria vary by study, often including age, MS type, disease activity, and prior treatments. Researchers use these criteria to ensure patient safety and gather relevant data. Information on specific requirements is available on ClinicalTrials.gov.
What are the different phases of clinical trials for MS?
Clinical trials for MS typically progress through phases, from early safety testing (Phase 1) to evaluating effectiveness and side effects in larger groups (Phases 2 and 3). Phase 4 studies monitor long-term safety. Details on trial phases are found on ClinicalTrials.gov.
Do multiple sclerosis clinical trials cost money to join?
Generally, participants in clinical trials do not pay for study-related treatments or procedures. Some trials may cover travel or other expenses. It's important to discuss potential costs with the study team before enrolling, as outlined on ClinicalTrials.gov.
What are current research directions in multiple sclerosis clinical trials?
Current research explores neuroprotective strategies, remyelination therapies to repair nerve damage, and treatments targeting progressive forms of MS. Studies also investigate new ways to manage symptoms and improve quality of life, as seen on ClinicalTrials.gov and NIH RePORTER.
What types of interventions are being studied for MS?
Interventions include new disease-modifying therapies (DMTs), cell-based therapies, symptom management drugs, and rehabilitation strategies. Researchers are also exploring dietary and lifestyle interventions. Details are available on ClinicalTrials.gov and NIH RePORTER.
Are there specific biomarkers important in MS clinical trials?
Biomarkers like neurofilament light chain (NfL) in blood or CSF, MRI lesion activity, and optical coherence tomography (OCT) are studied. These help track disease progression, treatment response, and predict outcomes, as indicated by NIH RePORTER.
What are common reasons someone might be excluded from an MS trial?
Common exclusion criteria can include certain co-existing medical conditions, pregnancy, breastfeeding, recent use of specific medications, or a history of other autoimmune diseases. These vary by study protocol and are listed on ClinicalTrials.gov.
Do all MS clinical trials use a placebo?
Not all MS clinical trials use a placebo. Some compare a new treatment to an existing standard therapy, while others may be open-label. The study design, including whether a placebo is used, is clearly explained to participants on ClinicalTrials.gov.
How to find a multiple sclerosis trial that fits you
- Describe your multiple sclerosis situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.
Browse all multiple sclerosis trials →